USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Douglas Pharmaceuticals Limited

USPTO PatentsView assignee record - 14 granted patents across 3 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Douglas ranks #19,680 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 3 technology areas.

#19,680
of 49,997 US assignees by volume
Top 40%
by Innovation Score (38.8/100)
22.1
avg claims per patent
+350%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19680 · Foreign Corporation #19,680 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #19,680/49,997
  • PHOTO-FINISH DG Holdings
  • CPC-NARROW A61K · 3 areas
  • INNOV-THIN 38.8/100
  • CLAIMS-DENSE 22.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +350% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: DG Holdings, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Douglas’s 38.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Douglas

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Douglas's Innovation Score is 38.8/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Douglas?

Each dot is one of Douglas’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Douglas’s own 22.1 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Douglas vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 510152025 Granted patents (volume) Avg claims / patent DG Holdings, Inc. - 14, 17.36DG HoldingsDiality Inc. - 14, 8.64DialityDongguan NVT Technology Limited - 14, 16.21Dongguan NVT Tech…Dongguan YIH TEH Electric Products Co., Ltd. - 14, 13.71Dongguan YIH TEH…Dover Bmcs Acquisition Corp. - 14, 20.29Dover Bmcs Acquis…Driving Management Systems, Inc. - 14, 16.29Driving Managemen…Dropsa S.p.A. - 14, 16.36Dropsa S p ADuquesne University OF THE Holy Ghost - 14, 7.93Duquesne Universi…Douglas Pharmaceuticals Limited - 14, 22.14Douglas Pharmaceu…
Douglas vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Douglas's grants concentrate

Douglas Pharmaceuticals Limited is a focused PatentsView assignee: 3 CPC subclasses with 92.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2016. By volume, Douglas sits between DG Holdings, Inc. and Duquesne University OF THE Holy Ghost.

Douglas's three-year grant acceleration

Douglas Pharmaceuticals Limited shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Douglas's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Douglas holds 14 patents at rank #19,661, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Douglas

By rank, the assignees closest to #19,661 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Douglas's primary technology class.

Douglas's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20162019202020212022202320242025 3
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Douglas Pharmaceuticals Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 7.1%
2019 1 7.1%
2020 2 14.3%
2021 1 7.1%
2022 2 14.3%
2023 1 7.1%
2024 3 21.4%
2025partial year 3 21.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Douglas Pharmaceuticals Limited's patent record in context - here's where to go next.

  • Douglas Pharmaceuticals Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 92.9% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #19,680 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Douglas Pharmaceuticals Limited against DG Holdings, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.